TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 266 filers reported holding TANDEM DIABETES CARE INC in Q2 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $55,865,000 | -22.7% | 480,397 | +0.1% | 0.15% | -9.7% |
| Q4 2021 | $72,244,000 | +443.3% | 479,965 | +245.4% | 0.16% | +371.4% |
| Q4 2020 | $13,297,000 | -72.5% | 138,971 | -67.4% | 0.04% | -77.4% |
| Q3 2020 | $48,440,000 | +21.6% | 426,780 | +6.0% | 0.16% | +11.5% |
| Q2 2020 | $39,842,000 | +207.9% | 402,768 | +85.6% | 0.14% | +223.3% |
| Q4 2019 | $12,939,000 | -73.0% | 217,061 | -73.3% | 0.04% | -73.6% |
| Q3 2019 | $47,929,000 | -53.0% | 812,625 | -48.6% | 0.16% | -50.9% |
| Q2 2019 | $102,046,000 | -8.7% | 1,581,620 | -10.1% | 0.33% | -10.8% |
| Q1 2019 | $111,757,000 | +62.5% | 1,759,958 | -2.8% | 0.37% | +48.2% |
| Q4 2018 | $68,762,000 | +11.0% | 1,810,966 | +25.3% | 0.25% | +45.9% |
| Q3 2018 | $61,934,000 | +470.3% | 1,445,705 | +193.1% | 0.17% | +437.5% |
| Q2 2018 | $10,860,000 | – | 493,199 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |